Paper42898534PubMed
Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies.
Tian Y and 3 others. Front Pharmacol, 2026.
Cite this record
ConductScience Library. Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies. Papers, record 42898534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42898534
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies.
- Journal
- Front Pharmacol
- Year
- 2026
- Publication types
- Journal Article, Systematic Review
- Revised in PubMed
- 2026-10-22
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22300229 | Improving cognitive outcome in cerebral malaria: insights from clinical and experimental research. | Cent Nerv Syst Agents Med Chem | 2011 | https://conductscience.org/library/papers/22300229 | PubMed |
| 2 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 3 | 25541544 | Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare. | ILAR J | 2014 | https://conductscience.org/library/papers/25541544 | PubMed |
| 4 | 24667063 | SYRCLE's risk of bias tool for animal studies. | BMC Med Res Methodol | 2014 | https://conductscience.org/library/papers/24667063 | PubMed |
| 5 | 24411643 | Biomedical research: increasing value, reducing waste. | Lancet | 2014 | https://conductscience.org/library/papers/24411643 | PubMed |
| 6 | 39343990 | The Potential Role of Artemisinins Against Neurodegenerative Diseases. | Am J Chin Med | 2024 | https://conductscience.org/library/papers/39343990 | PubMed |
| 7 | 28058794 | Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. | Res Synth Methods | 2017 | https://conductscience.org/library/papers/28058794 | PubMed |
| 8 | 33038880 | Cognitive dysfunctions in depression - significance, description and treatment prospects. | Psychiatr Pol | 2020 | https://conductscience.org/library/papers/33038880 | PubMed |
| 9 | 27733935 | Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study. | BJPsych Open | 2016 | https://conductscience.org/library/papers/27733935 | PubMed |
| 10 | 41181594 | Artemisinin exerts antidepressant-like effects via activation of AKT and ERK signaling pathways. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41181594 | PubMed |
| 11 | 40943352 | Artemisinin and Its Derivatives from Molecular Mechanisms to Clinical Applications: New Horizons Beyond Antimalarials. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943352 | PubMed |
| 12 | 38552734 | Dihydroartemisinin Protects Mice from CUMS-induced Depression-like Behaviors by Regulating Gut Microbes. | Neuroscience | 2024 | https://conductscience.org/library/papers/38552734 | PubMed |
| 13 | 29470495 | Reproducibility of preclinical animal research improves with heterogeneity of study samples. | PLoS Biol | 2018 | https://conductscience.org/library/papers/29470495 | PubMed |
| 14 | 37713568 | Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. | World Psychiatry | 2023 | https://conductscience.org/library/papers/37713568 | PubMed |
| 15 | 35026139 | Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. | Lancet Psychiatry | 2022 | https://conductscience.org/library/papers/35026139 | PubMed |
| 16 | 30200699 | [Application of three artemisinin derivatives in neuropathic pain: evaluating co-curation of nociceptive and emotional syndromes in spinal cord ligation mice]. | Zhongguo Zhong Yao Za Zhi | 2018 | https://conductscience.org/library/papers/30200699 | PubMed |
| 17 | 30025524 | The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses. | BMC Med | 2018 | https://conductscience.org/library/papers/30025524 | PubMed |
| 18 | 20361022 | Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. | PLoS Biol | 2010 | https://conductscience.org/library/papers/20361022 | PubMed |
| 19 | 35683033 | Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35683033 | PubMed |
| 20 | 37331451 | Effects of Artemisia annua L. on postmenopausal syndrome in ovariectomized mice. | J Ethnopharmacol | 2023 | https://conductscience.org/library/papers/37331451 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42898534
GET https://conductscience.org/api/papers/v1/42898534/references?page=2